Basic Information
Corporate Information [PDF: 414KB]
| Company Name |
Mitsubishi Tanabe Pharma Corporation |
| Capital Stock |
50 billion yen |
| President&Representative Director |
UENO Hiroaki |
| Headquarters |
3-2-10, Dosho-machi, Chuo-ku,
Osaka 541-8505, Japan
TEL: 81-6-6205-5085 |
| Number of Employees |
6,728 (Consolidated) 3,383 (Non-consolidated）（As of March 31, 2021） |
| Incorporated |
December 13, 1933 |
| Date of Merger |
October 1, 2007 |
Business Activities
Pharmaceuticals
Manufacture and sale of pharmaceuticals, centered on ethical drugs
Major Ethical Drugs
Central nervous system
| Lexapro |
anti-depressant agent |
| Radicut (Radicava) |
cerebral neuroprotectant |
Immuno-inflammation
| Remicade |
agent for treatment of rheumatoid arthritis, Crohn’s disease, Bechet’s disease with refractory uveoretinitis, psoriasis, ankylosing spondylitis, ulcerative colitis and Kawasaki disease |
| Simponi |
agent for treatment of rheumatoid arthritis and ulcerative colitis |
| Stelara |
agent for treatment of Crohn’s disease |
| Imusera |
agent for treatment of multiple sclerosis |
Others
| Tenelia |
agent for treatment of type Ⅱ diabetes mellitus |
| Canaglu |
agent for treatment of type Ⅱ diabetes mellitus |
| Canalia |
agent for treatment of type Ⅱ diabetes mellitus |
| Vafseo |
agent for treatment of renal anemia |
| Rupafin |
agent for treatment of allergic disorders |
Vaccines
| Influenza vaccine |
|
| TETRABIK |
combined vaccine for diphtheria, pertussis, tetanus and poliomyelitis (polio) |
| Mearubik |
combined vaccine for measles and rubella |
| JEBIK V |
vaccine for Japanese encephalitis |
| Varicella vaccine |
|
Major OTC Products
- Flucort f (agent for treatment of skin conditions)
- Cort f series (agent for treatment of skin conditions)
- Tanabe ichoyaku〈choritsu〉(digestive medicine)
- Tanabe ichoyaku urso (digestive medicine)
- Urso ukon (digestive drink)
- Cerekinon S (digestive medicine)
- Aspara drink α (nutrient and tonic drink)
